Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo

Diabetes Research and Clinical Practice

Volumn 93, Issue 2, 2011, Pages 205-214

  Li, Yan ^a   Zhao, Sheng ^a   Zhang, Wei ^a   Zhao, Peng ^a   He, Bing ^a   Wu, Na ^a   Han, Ping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

AMP activated protein kinase; Epigallocatechin 3 O gallate; Free fatty acids; Insulin receptor substrate 1; Insulin resistance

Indexed keywords

8 ISOPROSTAGLANDIN E2; BIOLOGICAL MARKER; EPIGALLOCATECHIN GALLATE; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; GLUTATHIONE PEROXIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MALONALDEHYDE; PROTEIN KINASE B; PROTEIN KINASE C; SERINE; SUPEROXIDE DISMUTASE; THREONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT DISTRIBUTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG MUSCLE LEVEL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LOW DRUG DOSE; MALE; MEMBRANE TRANSPORT; NONHUMAN; OXIDATIVE STRESS; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE DISTRIBUTION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CATECHIN; DRUG THERAPY, COMBINATION; FATTY ACIDS, NONESTERIFIED; GLUCOSE CLAMP TECHNIQUE; INSULIN; INSULIN RESISTANCE; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 80051564679     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.03.036     Document Type: Article

References (50)

1. Roden M., Stingl H., Chandramouli V., Schumann W.C., Hofer A., Landau B.R., et al. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 2000, 49(5):701-707.
2. Ye J.M., Frangioudakis G., Iglesias M.A., Furler S.M., Ellis B., Dzamko N., et al. Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver. Endocrinology 2002, 143(12):4527-4535.
3. Kruszynska Y.T., Worrall D.S., Ofrecio J., Frias J.P., Macaraeg G., Olefsky J.M. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. J Clin Endocrinol Metab 2002, 87(1):226-234.
4. Lam T.K., van de Werve G., Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab 2003, 284(2):E281-E290.
5. Wu L.Y., Juan C.C., Ho L.T., Hsu Y.P., Hwang L.S. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J Agric Food Chem 2004, 52(3):643-648.
6. Anderson R.A., Polansky M.M. Tea enhances insulin activity. J Agric Food Chem 2002, 50(24):7182-7186.
7. Carobbio S., Ishihara H., Fernandez-Pascual S., Bartley C., Martin-Del-Rio R., Maechler P. Insulin secretion profiles are modified by overexpression of glutamate dehydrogenase in pancreatic islets. Diabetologia 2004, 47(2):266-276.
8. Wolfram S., Raederstorff D., Preller M., Wang Y., Teixeira S.R., Riegger C., et al. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 2006, 136(10):2512-2518.
9. Potenza M.A., Marasciulo F.L., Tarquinio M., Tiravanti E., Colantuono G., Federici A., et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 2007, 292(5):E1378-E1387.
10. Bose M., Lambert J.D., Ju J., Reuhl K.R., Shapses S.A., Yang C.S. The major green tea polyphenol (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 2008, 138(9):1677-1683.
11. Luo Z., Saha A.K., Xiang X., Ruderman N.B. AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 2005, 26(2):69-76.
12. Hwang J.T., Park I.J., Shin J.I., Lee Y.K., Lee S.K., Baik H.W., et al. Genistein EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005, 338(2):694-699.
13. Murase T., Misawa K., Haramizu S., Hase T. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem Pharmacol 2009, 78(1):78-84.
14. Lin C.L., Lin J.K. Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. Mol Nutr Food Res 2008, 52(8):930-939.
15. Zhang Z.F., Li Q., Liang J., Dai X.Q., Ding Y., Wang J.B., et al. Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition. Phytomedicine 2010, 17(1):14-18.
16. He B., Zhao S., Zhang W., Li Y., Lu Y., Han P. Salicylate prevents hepatic oxidative stress activation caused by short-term elevation of free fatty acids in vivo. Diabetes Res Clin Pract 2010, 89(2):150-156.
17. Pospisilik J.A., Stafford S.G., Demuth H.U., McIntosh C.H., Pederson R.A. Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study. Diabetes 2002, 51(9):2677-2683.
18. Dube J.J., Bhatt B.A., Dedousis N., Bonen A., O'Doherty R.M. Leptin, skeletal muscle lipids, and lipid-induced insulin resistance. Am J Physiol Regul Integr Comp Physiol 2007, 293(2). R642 650.
19. Commerford S.R., Peng L., Dube J.J., O'Doherty R.M. In vivo regulation of SREBP-1c in skeletal muscle: effects of nutritional status, glucose, insulin, and leptin. Am J Physiol Regul Integr Comp Physiol 2004, 287(1). R218 227.
20. Krssak M., Falk Petersen K., Dresner A., DiPietro L., Vogel S.M., Rothman D.L., et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999, 42(1):113-116.
21. Pan D.A., Lillioja S., Kriketos A.D., Milner M.R., Baur L.A., Bogardus C., et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997, 46(6):983-988.
22. Li L., Yang G.Y. Effect of hepatic glucose production on acute insulin resistance induced by lipid-infusion in awake rats. World J Gastroenterol 2004, 10(21):3208-3211.
23. Lam T.K., Carpentier A., Lewis G.F., van de Werve G., Fantus I.G., Giacca A. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab 2003, 284(5):E863-E873.
24. Boden G. Fatty acids and insulin resistance. Diabetes Care 1996, 19(4):394-395.
25. Han P., Zhang Y.Y., Lu Y., He B., Zhang W., Xia F. Effects of different free fatty acids on insulin resistance in rats. Hepatobiliary Pancreat Dis Int 2008, 7(1):91-96.
26. He B., Zhao S., Zhang W., Li Y., Han P. Effect of sodium salicylate on oxidative stress and insulin resistance induced by free fatty acids. Hepatobiliary Pancreat Dis Int 2010, 9(1):49-53.
27. Thirone A.C., Huang C., Klip A. Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends Endocrinol Metab 2006, 17(2):72-78.
28. Liu Y.F., Herschkovitz A., Boura-Halfon S., Ronen D., Paz K., Leroith D., et al. Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance. Mol Cell Biol 2004, 24(21):9668-9681.
29. Frangioudakis G., Cooney G.J. Acute elevation of circulating fatty acids impairs downstream insulin signalling in rat skeletal muscle in vivo independent of effects on stress signalling. J Endocrinol 2008, 197(2):277-285.
30. Gao Z., Zhang X., Zuberi A., Hwang D., Quon M.J., Lefevre M., et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol 2004, 18(8):2024-2034.
31. Park E., Wong V., Guan X., Oprescu A.I., Giacca A. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo. J Endocrinol 2007, 195(2):323-331.
32. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999, 48(6):1270-1274.
33. Kim J.K., Fillmore J.J., Sunshine M.J., Albrecht B., Higashimori T., Kim D.W., et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest 2004, 114(6):823-827.
34. Tang E.Y., Parker P.J., Beattie J., Houslay M.D. Diabetes induces selective alterations in the expression of protein kinase C isoforms in hepatocytes. FEBS Lett 1993, 326(1-3):117-123.
35. Lee S.F., Lin J.K. Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells. Nutr Cancer 1997, 28(2):177-183.
36. Nakamura S., Takamura T., Matsuzawa-Nagata N., Takayama H., Misu H., Noda H., et al. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem 2009, 284(22):14809-14818.
37. Paolisso G., Gambardella A., Tagliamonte M.R., Saccomanno F., Salvatore T., Gualdiero P., et al. Does free fatty acid infusion impair insulin action also through an increase in oxidative stress?. J Clin Endocrinol Metab 1996, 81(12):4244-4248.
38. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C - dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000, 49(11):1939-1945.
39. Lee H.B., Yu M.R., Song J.S., Ha H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 2004, 65(4):1170-1179.
40. Ramesh E., Elanchezhian R., Sakthivel M., Jayakumar T., Senthil Kumar R.S., Geraldine P., et al. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet. Fundam Clin Pharmacol 2008, 22(3):275-284.
41. Ramesh E., Jayakumar T., Elanchezhian R., Sakthivel M., Geraldine P., Thomas P.A. Green tea catechins, alleviate hepatic lipidemic-oxidative injury in Wistar rats fed an atherogenic diet. Chem Biol Interact 2009, 180(1):10-19.
42. Ueno T., Torimura T., Nakamura T., Sivakumar R., Nakayama H., Otabe S., et al. Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue. Int J Mol Med 2009, 24(1):17-22.
43. Carpentier A.C., Frisch F., Cyr D., Genereux P., Patterson B.W., Giguere R., et al. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans. Am J Physiol Endocrinol Metab 2005, 289(5):E849-E856.
44. Larbi A., Grenier A., Frisch F., Douziech N., Fortin C., Carpentier A.C., et al. Acute in vivo elevation of intravascular triacylglycerol lipolysis impairs peripheral T cell activation in humans. Am J Clin Nutr 2005, 82(5):949-956.
45. Wu N., Lu Y., He B., Zhang Y., Lin J., Zhao S., et al. Taurine prevents free fatty acid-induced hepatic insulin resistance in association with inhibiting JNK1 activation and improving insulin signaling in vivo. Diabetes Res Clin Pract 2010, 90(3):288-296.
46. Babu P.V., Liu D. Green tea catechins and cardiovascular health: an update. Curr Med Chem 2008, 15(18):1840-1850.
47. Niedowicz D.M., Daleke D.L. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005, 43(2):289-330.
48. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114(12):1752-1761.
49. Ruderman N., Prentki M. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 2004, 3(4):340-351.
50. Yang Z., Kahn B.B., Shi H., Xue B.Z. Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem 2010, 285(25):19051-19059.